VOYA Investment Management
TERN

VOYA Investment Management’s Terns Pharmaceuticals TERN Stock Holding History

VOYA Investment Management’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.73M Buy
165,562
+43,167
+35% +$1.77M 0.01% 664
2025
Q4 		$4.94M Buy
122,395
+108,729
+796% +$2.51M ﹤0.01% 870
2025
Q3 		$103K Sell
13,666
-6,515
-32% -$41.6K ﹤0.01% 2298
2025
Q2 		$75.3K Buy
20,181
+385
+2% +$1.2K ﹤0.01% 2540
2025
Q1 		$54.6K Sell
19,796
-684
-3% -$2.79K ﹤0.01% 2534
2024
Q4 		$113K Buy
20,480
+1,313
+7% +$8.89K ﹤0.01% 2552
2024
Q3 		$160K Sell
19,167
-456
-2% -$3.75K ﹤0.01% 2544
2024
Q2 		$134K Buy
19,623
+5,370
+38% +$32.5K ﹤0.01% 2596
2024
Q1 		$93.5K Sell
14,253
-3,626
-20% -$23.7K ﹤0.01% 2629
2023
Q4 		$116K Hold
17,879
– – ﹤0.01% 2723
2023
Q3 		$89.9K Buy
17,879
+783
+5% +$4.97K ﹤0.01% 2758
2023
Q2 		$150K Buy
+17,096
New +$199K ﹤0.01% 2681

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

VOYA Investment Management's TERN Position: Q1 2026 in Review

VOYA Investment Management increased its Terns Pharmaceuticals (TERN) stake by 35% in Q1 2026, buying an estimated $1.77M and bringing the position to 165,562 shares worth $8.73M. The position accounts for 0.01% of the portfolio, ranked #664.

VOYA Investment Management first reported a position in TERN in Q2 2023 and has held it in 12 quarters since. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • VOYA Investment Management held 165,562 shares of Terns Pharmaceuticals worth $8.73M as of Q1 2026.
  • VOYA Investment Management bought 43,167 Terns Pharmaceuticals shares in Q1 2026, an estimated $1.77M.
  • Terns Pharmaceuticals made up 0.01% of VOYA Investment Management's portfolio in Q1 2026, its #664 holding.
  • VOYA Investment Management first reported a position in Terns Pharmaceuticals in Q2 2023 and has held it in 12 quarters since.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.